
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nanobodies: COVID-19 and Future Perspectives
G Valenzuela, Zaray Miranda-Chacón, Constanza Salinas-Rebolledo, et al.
Frontiers in Drug Discovery (2022) Vol. 2
Open Access | Times Cited: 13
G Valenzuela, Zaray Miranda-Chacón, Constanza Salinas-Rebolledo, et al.
Frontiers in Drug Discovery (2022) Vol. 2
Open Access | Times Cited: 13
Showing 13 citing articles:
Discovery of nanobodies: a comprehensive review of their applications and potential over the past five years
Elena Alexander, Kam W. Leong
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Elena Alexander, Kam W. Leong
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10
SARS-CoV-2 Specific Nanobodies Neutralize Different Variants of Concern and Reduce Virus Load in the Brain of h-ACE2 Transgenic Mice
María F. Pavan, Marina Bok, Rafael Betanzos San Juan, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 185-185
Open Access | Times Cited: 5
María F. Pavan, Marina Bok, Rafael Betanzos San Juan, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 185-185
Open Access | Times Cited: 5
NANOBODY® Molecule, a Giga Medical Tool in Nanodimensions
Sarah Kunz, Manon Durandy, Laetitia Seguin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13229-13229
Open Access | Times Cited: 10
Sarah Kunz, Manon Durandy, Laetitia Seguin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13229-13229
Open Access | Times Cited: 10
Interaction of SARS-CoV-2 with host cells and antibodies: experiment and simulation
Hung Van Nguyen, Hoang Linh Nguyen, Pham Dang Lan, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 18, pp. 6497-6553
Closed Access | Times Cited: 9
Hung Van Nguyen, Hoang Linh Nguyen, Pham Dang Lan, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 18, pp. 6497-6553
Closed Access | Times Cited: 9
Structure-guided design of a trivalent nanobody cluster targeting SARS-CoV-2 spike protein
Xinyi Jiang, Qin Qin, Haixia Zhu, et al.
International Journal of Biological Macromolecules (2023) Vol. 256, pp. 128191-128191
Closed Access | Times Cited: 9
Xinyi Jiang, Qin Qin, Haixia Zhu, et al.
International Journal of Biological Macromolecules (2023) Vol. 256, pp. 128191-128191
Closed Access | Times Cited: 9
Development and Characterization of Phage-Display-Derived Novel Human Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2
Ji Woong Kim, Sung Won Min, Jichul Lee, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3274-3274
Open Access | Times Cited: 9
Ji Woong Kim, Sung Won Min, Jichul Lee, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3274-3274
Open Access | Times Cited: 9
Assessing nanobody interaction with SARS-CoV-2 Nsp9
Gennaro Esposito, Yamanappa Hunashal, Mathias Percipalle, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0303839-e0303839
Open Access | Times Cited: 1
Gennaro Esposito, Yamanappa Hunashal, Mathias Percipalle, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0303839-e0303839
Open Access | Times Cited: 1
Respiratory delivered vaccines: Current status and perspectives in rational formulation design
Lan Wu, Wenwen Xu, Huiyang Jiang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 12, pp. 5132-5160
Open Access | Times Cited: 1
Lan Wu, Wenwen Xu, Huiyang Jiang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 12, pp. 5132-5160
Open Access | Times Cited: 1
Redirecting a Broad-Spectrum Nanobody Against the Receptor-Binding Domain of SARS-CoV-2 to Target Omicron Variants
Kwanpet Intasurat, Nonth Submunkongtawee, Phoomintara Longsompurana, et al.
Applied Sciences (2024) Vol. 14, Iss. 22, pp. 10548-10548
Open Access | Times Cited: 1
Kwanpet Intasurat, Nonth Submunkongtawee, Phoomintara Longsompurana, et al.
Applied Sciences (2024) Vol. 14, Iss. 22, pp. 10548-10548
Open Access | Times Cited: 1
Nanobodies against SARS-CoV-2 reduced virus load in the brain of challenged mice and neutralized Wuhan, Delta and Omicron Variants
María F. Pavan, Marina Bok, Rafael Betanzos San Juan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
María F. Pavan, Marina Bok, Rafael Betanzos San Juan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Novel Library Assembly Technique for Developing Nanobodies Targeting IPNv VP2 Protein
Camila Pino-Belmar, Johanna Himelreichs, Camila Deride, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Camila Pino-Belmar, Johanna Himelreichs, Camila Deride, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Development and evaluation of an 18F-labeled nanobody to target SARS-CoV-2's spike protein
Sara Lopes van den Broek, Rocío García‐Vázquez, Ida Vang Andersen, et al.
Frontiers in Nuclear Medicine (2022) Vol. 2
Open Access | Times Cited: 1
Sara Lopes van den Broek, Rocío García‐Vázquez, Ida Vang Andersen, et al.
Frontiers in Nuclear Medicine (2022) Vol. 2
Open Access | Times Cited: 1
Assessing nanobody interaction with SARS-CoV-2 Nsp9
Gennaro Esposito, Yamanappa Hunashal, Mathias Percipalle, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Gennaro Esposito, Yamanappa Hunashal, Mathias Percipalle, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access